Tg Therapeutics (TGTX) Interest & Investment Income (2010 - 2019)
Tg Therapeutics (TGTX) recorded quarterly Interest & Investment Income of $1.1 million in Q2 2019, up 622.82% quarter-over-quarter from $149000.0 in Q1 2019, and up 382.96% on a YoY basis from $223000.0 in Q2 2018.
Tg Therapeutics (TGTX) Interest & Investment Income (2010 - 2019) Analysis & Trends
Tg Therapeutics' Interest & Investment Income history runs 9 years deep, the most recent figure standing at $1.1 million for Q2 2019.
- In Q2 2019, Interest & Investment Income rose 382.96% year-over-year to $1.1 million; the TTM figure through Jun 2019 stood at $1.8 million (up 208.64% YoY), while the FY2018 annual figure was $857000.0, up 190.51% from the prior year.
- Interest & Investment Income was $1.1 million for Q2 2019 at Tg Therapeutics, up from $149000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $1.1 million in Q2 2019 to a low of $22132.0 in Q1 2015.
- Historically, Interest & Investment Income has averaged $161647.4 across 5 years, with a median of $86413.5 in 2016.
- The sharpest annual moves came in 2017 and 2019: Interest & Investment Income tumbled 46.97% in 2017, then soared 382.96% in 2019.
- A 5-year view of Interest & Investment Income shows it stood at $64993.0 in 2015, then decreased by 11.46% to $57544.0 in 2016, then soared by 110.27% to $121000.0 in 2017, then soared by 119.83% to $266000.0 in 2018, then surged by 304.89% to $1.1 million in 2019.
- The last three Interest & Investment Income figures came in at $1.1 million (Q2 2019), $149000.0 (Q1 2019), and $266000.0 (Q4 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Tg Therapeutics | 7.71 Bn | 7.06 Bn | 171.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 1.08 Mn |
| Mar 31, 2019 | 149,000.00 |
| Dec 31, 2018 | 266,000.00 |
| Sep 30, 2018 | 258,000.00 |
| Jun 30, 2018 | 223,000.00 |
| Mar 31, 2018 | 144,000.00 |
| Dec 31, 2017 | 121,000.00 |
| Sep 30, 2017 | 79,000.00 |
| Jun 30, 2017 | 50,000.00 |
| Mar 31, 2017 | 45,000.00 |
| Dec 31, 2016 | 57,544.00 |
| Sep 30, 2016 | 87,965.00 |
| Jun 30, 2016 | 92,629.00 |
| Mar 31, 2016 | 84,862.00 |
| Dec 31, 2015 | 64,993.00 |
| Sep 30, 2015 | 55,977.00 |
| Jun 30, 2015 | 31,551.00 |
| Mar 31, 2015 | 22,132.00 |
| Dec 31, 2014 | 16,741.00 |
| Sep 30, 2014 | 12,107.00 |